arrow
Z

Zhi-Qiang Wang

中山大学
H指数:28
被引数:2,977

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The INSPECTOR study: enhanced feasibility for clinical translation of a multi-cancer early detection method based on enzyme-assisted high signal-to-noise ratio sequencing of methylated circulating tumor DNA

INSPECTOR研究:基于酶辅助高信噪比测序甲基化循环肿瘤DNA的多癌种早期检测方法的临床转化可行性提升

2025-10-300
OAAI
Association of Immunogenicity and Drug Exposure and the Importance of Target Engagement in ADA Development: A Clinical Case Study of Anti-SARS-CoV-2 Biotherapeutics

免疫原性与药物暴露的关联及靶点结合在ADA发展中的重要性:一项抗SARS-CoV-2生物制剂的临床病例研究

2025-10-230
OA
Corrigendum to “Copper-doped layered double hydroxides co-deliver proteins/drugs for cascaded chemodynamic/immunotherapy via dual regulation of tumor metabolism” [Acta Biomaterialia 2025, 195, 350-362]

勘误:“Copper-doped layered double hydroxides co-deliver proteins/drugs for cascaded chemodynamic/immunotherapy via dual regulation of tumor metabolism” [Acta Biomaterialia 2025, 195, 350-362]

2025-10-160
PRE
Safety of fruquintinib in Chinese patients with colorectal cancer: an age subgroup analysis from a phase IV real-world clinical practice study

fruquintinib在中国结直肠癌患者中的安全性:一项来自IV期真实世界临床实践研究的年龄亚组分析

2025-09-010
OA
Patterns and outcomes of early and late recurrence after hepatectomy for hepatocellular carcinoma with microvascular invasion: a multicenter study in China
2025-03-010
PRE
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial

联合anti-PD-1,HDAC抑制剂和抗VEGF治疗MSS/pMMR结直肠癌: 一项随机2期试验

2024-03-0422
PRE